News

December 3, 2020December 3, 2020

Anixa Biosciences, Cleveland Clinic Developing Breast Cancer Vaccine

News

Anixa Biosciences and the Cleveland Clinic have filed an investigational new drug application for a breast cancer vaccine with the U.S. Food and Drug Administration. The vaccine technology was developed ... Read more

November 30, 2020November 30, 2020

FDA Gives Breakthrough Device Status to 4D Path’s Breast Cancer Diagnostic Platform

News

The U.S. Food and Drug Administration (FDA) has designated 4D Path’s software a breakthrough device as a possible way to achieve a faster and more accurate breast cancer diagnosis based on tissue taken ... Read more

November 26, 2020November 26, 2020

New $100M Program Aims to Improve Diversity in Clinical Trials

News, syndicated

A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved patient ... Read more

November 23, 2020November 23, 2020

FDA Grants Fast Track Status, Rolling Review to Lumicell’s LUM Imaging System

News

The U.S. Food and Drug Administration (FDA) has granted fast track designation with rolling review to Lumicell’s LUM Imaging System for the detection and treatment of breast cancer. Fast track ... Read more

November 19, 2020November 19, 2020

FDA Approves Keytruda-chemo Combo for Advanced TNBC Positive for PD-L1

News

The U.S. Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab), in combination with chemotherapy, to treat people with advanced triple-negative breast cancer (TNBC) and at least 10% of tumor cells ... Read more

November 12, 2020November 12, 2020

Breast Cancer Cell Sugars in Liquid Biopsies Could Be Key to Early Detection

News

The sugars that breast cancer cells shed into the bloodstream could provide an early cancer warning, according to a press release from GlycoNet, Canada’s national network of sugar science researchers. ... Read more

November 9, 2020November 9, 2020

Athenex Oncology Offers Free ‘Evidenced-based’ Lifestyle Guide for MBC Patients

News

A new Athenex Oncology guide offers evidence-based lifestyle suggestions to metastatic breast cancer (MBC) patients to help improve their quality of life. The free booklet, called “Your Guide to Facing ... Read more

November 5, 2020November 5, 2020

Phase 3 Trial to Compare Enhertu to Kadcyla in HER2-Positive, High Risk Patients

News

Daiichi Sankyo and AstraZeneca are initiating a global Phase 3 trial to compare Enhertu (fam-trastuzumab deruxtecan-nxki) to Kadcyla (ado-trastuzumab emtansine, also called T-DM1) as adjuvant therapy in patients with HER2-positive early breast ... Read more

November 2, 2020November 2, 2020

FDA Approves FoundationOne Liquid CDx as Companion Diagnostic Test for Piqray Treatment

News

The U.S. Food and Drug Administration (FDA) has expanded the approval of Foundation Medicine’s FoundationOne Liquid CDx as a companion diagnostic test for identifying advanced or metastatic breast cancer patients suitable for treatment ... Read more

October 29, 2020October 29, 2020

FDA Grants Fast Track to PC14586, Potential Therapy for Specific p53 Mutation

News

The U.S. Food and Drug Administration (FDA) has granted fast track status to PC14586, PMV Pharmaceuticals’ lead therapeutic candidate for the treatment of patients with locally advanced or metastatic solid ... Read more